About 70,000 adults and children in the UK have Polycystic Kidney Disease or PKD - life-threatening inherited conditions that can cause renal (kidney) failure and affect other organs in the body.

We support those affected, their families and carers. We raise awareness and fund research.

Find out more about PKD.


0300 111 1234

Welcome to the PKD Charity

Find out more about PKD

ADPKD - AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - is the world’s most common inherited kidney disease, in which fluid-filled cysts develop, multiply and grow in both kidneys. Other organs, such as the liver and brain, may be affected. Between 1 in 400 and 1 in 1000 people worldwide - about 12.5 million - have ADPKD. Over half of those affected will have kidney failure by the time they are 60 years old. Many will experience regular pain, disabiity and anxiety throughout life. If someone has ADPKD, there is a 1 in 2 (50 percent) likelihood that the disease will pass to each child born.

Read more about ADPKD.

ARPKD - AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE - is a rare disease that affects the kidneys and liver. It occurs in about one in every 20,000 live births in the UK. ARPKD is a severe disease. Sadly, about one baby in three with ARPKD dies from breathing problems during the first four weeks after birth and some will die during pregnancy. However, 8 to 9 in ten babies (80-90 per cent) who survive the first four weeks of life are still alive at five years old. Encouragingly, a good number of children  now survive into adulthood and are able to live full and productive lives.

Read more about ARPKD.


Latest News & Events

Spring Ball in aid of PKD Charity – 5th March 2016

Join us for a very special evening to raise funds for PKD Charity organised by PKD Charity’s Events and Fundraising Manager, Esther Wright.

Read more ...

PKD and Children - World Kidney Day 10 March 2016

Help us unite with one powerful voice for World Kidney Day 2016 by organising an activity or event in to draw public attention to the importance of kidneys. This year there is a particular focus on kidney disease in children.

Read more ...

SMC Accepts Tolvaptan (JINARC®) to Treat ADPKD in Scotland

11 January 2016:The Polycystic Kidney Disease (PKD) Charity is delighted that the Scottish Medicines Consortium (SMC) Committee has, after careful consideration of all the evidence, decided to accept tolvaptan (brand name: JINARC®) for routine use by NHS Scotland.

Read more ...

Latest Research

Tolvaptan - 'JINARC' - has been recommended for a license in Europe

The European Medicines Agency (EMA) has recommended granting a marketing authorisation to tolvaptan, which now has the brand name: JINARC.

Read more ...

Apply for a Research Grant

PKD Charity Grant Programme

The PKD Charity has announced its first Grant Programme. The trustees have agreed to award 3 grants in the region of £10,000 each to UK researchers.

Read more ...

Latest Tweets

PKD Charity is a Member of